Atlas Trials

A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas

Clinical trial NCT06490757 · RECRUITING

Trial details

NCT number
NCT06490757
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Inflammatory Hepatocellular Adenoma
Start date
2024-10-02
Primary completion
2028-09-02
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.